• Blog
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Report

    Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Report

    Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Report
    Report code - SR1409 Delivery - 2 Weeks
    Get Free Sample |
    Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Trends, Dynamics &am See more...

    Impact of COVID-19 on Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market is estimated to grow from USD xx million in 2020 to USD xx million by 2026 at a healthy CAGR of 3.6% during the forecast period.

    Figure: Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market Size, 2020-2026 (USD Million)

    Percutaneous-Transluminal-Coronary-Angioplasty-(PTCA)-Products-Market-Forecast

    Wish to get a free sample? Register Here

    What is percutaneous transluminal coronary angioplasty?

    Percutaneous transluminal coronary angioplasty could be a minimally invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). Coronary heart diseases are primarily caused by smoking, resulting in an unhealthy lifestyle, high pressure level, diabetes, and a high level of cholesterol within the blood.

    Key Players

    Key players operating in the Percutaneous Transluminal Coronary Angioplasty (PTCA) products market are-

    • Abbott Laboratories (US)
    • Terumo (Japan)
    • Boston Scientific (US)
    • Intact Vascular (US)
    • Asahi Intecc (Japan)
    • Angioscore (US)
    • Bard PV (US)
    • Cook Medical (US)
    • Cordis (US)
    • Medtronic (US).

    Market Dynamics

    The increasing geriatric population, as well as lifestyle changes, leads to obesity, hypertension, hypertension, high blood pressure, and high level of cholesterol in the blood. Moreover, the growing prevalence of cardiovascular disease is likely to propel the growth of the percutaneous transluminal coronary angioplasty products market. In addition, the launch of advanced products and reclassification of some PTCA catheters from class III to class II devices by the FDA further augments the product demand.

    Segments' Analysis

    Product Trends

    Based on the product, the market has been bifurcated into PTCA balloon and PTCA guide. The infectious diseases segment accounted for a substantial market share in 2020. This is mainly attributed to rising cases of cardiovascular diseases across the globe. Also, the PTCA balloon is easy to use and safe. In addition, the cost associated with the PTCA balloon is relatively low, is likely to segment growth in the coming years.

    Regional Trends

    The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to enhanced healthcare infrastructure coupled with several government initiatives. The growing incidences of cardiac disorders have further led to a surge in the demand for percutaneous transluminal coronary angioplasty products. A well-established healthcare system and high per capita healthcare expenditure are further augmenting up the growth of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market in the region.

    COVID-19 Impact on Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market

    The COVID-19 outbreak positively influenced the growth of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. Senior adults and people suffering from cardiovascular diseases were at higher risk of getting infected, which, in turn, boosted the demand for PTCA products.

    Critical Questions Answered in the Report

    • What are the key trends in the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market?
    • What are the key strategies adopted by the major vendors to lead in the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Products market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the Percutaneous Transluminal Coronary Angioplasty (PTCA) Products Market hopes to have the greatest opportunity to convert-

    • Percutaneous Transluminal Coronary Angioplasty (PTCA) Products distributors
    • Percutaneous Transluminal Coronary Angioplasty (PTCA) Products suppliers
    • Percutaneous Transluminal Coronary Angioplasty (PTCA) Products manufacturers
    • Hospitals
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The percutaneous transluminal coronary angioplasty products market is expected to witness an impressive growth of 3.6% CAGR in the coming years.

    Abbott Laboratories (US), Terumo (Japan), Boston Scientific (US), Intact Vascular (US), Asahi Intecc (Japan), Angioscore (US), Bard PV (US), Cook Medical (US), Cordis (US), and Medtronic (US) are among the key player in the market.

    The increasing geriatric population, as well as lifestyle changes, growing prevalence of cardiovascular disease are the factors driving the growth of percutaneous transluminal coronary angioplasty products market.

    The infectious diseases segment accounted for a substantial CAGR in the percutaneous transluminal coronary angioplasty products market in 2020.

    North America is expected to remain dominant in the percutaneous transluminal coronary angioplasty products market in the next five years.

    Percutaneous Transluminal Coronary Angioplasty (PTCA) Products distributors, Percutaneous Transluminal Coronary Angioplasty (PTCA) Products suppliers, Percutaneous Transluminal Coronary Angioplasty (PTCA) Products manufacturers, Hospitals, Government bodies are the target audience in the percutaneous transluminal coronary angioplasty products market.

    //